APA (7th ed.) Citation

Dubashi, B., Matta, K., Kayal, S., Thumathy, D., Nisha, Y., Dharanipragada, K., . . . Ganesan, P. (2022). Modified neoadjuvant clinicopathological risk stratification as a prognostic score in early and locally advanced triple-negative breast cancer. Journal of Cancer Research & Therapeutics, 18(1), 168. https://doi.org/10.4103/jcrt.JCRT_986_20

Chicago Style (17th ed.) Citation

Dubashi, Biswajit, Kirankumar Matta, Smita Kayal, Divya Thumathy, Yadav Nisha, Kadambari Dharanipragada, Karunanithi Gunaseelan, Pampa ch Toi, and Prasanth Ganesan. "Modified Neoadjuvant Clinicopathological Risk Stratification as a Prognostic Score in Early and Locally Advanced Triple-negative Breast Cancer." Journal of Cancer Research & Therapeutics 18, no. 1 (2022): 168. https://doi.org/10.4103/jcrt.JCRT_986_20.

MLA (9th ed.) Citation

Dubashi, Biswajit, et al. "Modified Neoadjuvant Clinicopathological Risk Stratification as a Prognostic Score in Early and Locally Advanced Triple-negative Breast Cancer." Journal of Cancer Research & Therapeutics, vol. 18, no. 1, 2022, p. 168, https://doi.org/10.4103/jcrt.JCRT_986_20.